drugset / Trial / NCT03796884
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
Phase 2
Active not recruiting
150 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
United States Department of Defense · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This phase II trial studies the how well linaclotide works in treating patients with stages 0-3 colorectal cancer. Linaclotide is a very small protein that binds to receptors on intestinal cells and makes them secrete water and salt.
Timeline
- Start
- 2019-10-30
- Primary completion
- 2026-11
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linaclotide | Peptide | — | Oral |